Replimune (REPL) Interest & Investment Income (2018 - 2026)
Replimune (REPL) posted Interest & Investment Income of $1.96 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 58.4% from $4.71 million a year earlier and down 17.3% from the prior quarter.
Replimune (REPL) Interest & Investment Income (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Replimune was $10.87 million, down 48.5% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $13.63 million, down 35.5% from FY2025.
- Annual Interest & Investment Income shows a five-year compound annual growth rate of 71.6% (FY2021 to FY2026).
- In prior fiscal years, Replimune's Interest & Investment Income was $21.12 million in FY2025 (-9.6%), $23.36 million in FY2024 (+133.4%), $10.01 million in FY2023 and $390,000 in FY2022 (-57.4%).
- The fiscal Q1 2027 figure stands as the lowest quarterly Interest & Investment Income since fiscal Q2 2023.
- On a year-over-year basis, Interest & Investment Income has declined in each of the last four quarters, with an average decline of 25.8% over the last eight quarters.
- The strongest year-over-year quarter for Interest & Investment Income in the past five years was fiscal Q2 2024, with growth of 444.0%; the weakest was fiscal Q4 2026, with a decline of 59.7%.
- According to Business Quant data, Interest & Investment Income for the three prior fiscal quarters was $2.37 million (Q4 2026), $2.85 million (Q3 2026) and $3.7 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Replimune | 1.10 Bn | 1.10 Bn | - | 1.96 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.96 Mn |
| Mar 31, 2026 | 2.37 Mn |
| Dec 31, 2025 | 2.85 Mn |
| Sep 30, 2025 | 3.70 Mn |
| Jun 30, 2025 | 4.71 Mn |
| Mar 31, 2025 | 5.88 Mn |
| Dec 31, 2024 | 5.14 Mn |
| Sep 30, 2024 | 5.39 Mn |
| Jun 30, 2024 | 4.71 Mn |
| Mar 31, 2024 | 5.43 Mn |
| Dec 31, 2023 | 5.69 Mn |
| Sep 30, 2023 | 6.05 Mn |
| Jun 30, 2023 | 6.19 Mn |
| Mar 31, 2023 | 5.88 Mn |
| Dec 31, 2022 | 2.68 Mn |
| Sep 30, 2022 | 1.11 Mn |
| Jun 30, 2022 | 343,000.00 |
| Mar 31, 2022 | 131,000.00 |
| Dec 31, 2021 | 87,000.00 |
| Sep 30, 2021 | 80,000.00 |
Replimune Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();